glp-1 drugs alzheimer's Novo Nordisk's oral drug didn't work on as hoped, but don't call it a failure How GLP-1s Could Transform Alzheimer's
Description
That prospect already had food companies running scared more than a year ago
Blockbuster Drugs Leading the Charge: Wegovy (semaglutide): Approved for chronic weight management, demonstrating up to 15-20% weight loss
Both alcohol use and alcohol related deaths increased in the US during the COVID-19 pandemic 5,6
However, the small study population, open-label design and the lack of blindness are significant limitations that need to be considered when interpreting the data
Shared decision-making remains central
